Sorafenib tosylate

• Post Date:

  Dec 07,2018

• Expiry Date:

  Jun 05,2019

• Detailed Description:

  Cas No. :475207-59-1 Use in Cancer
  
  Sorafenib tosylate is approved to treat:
  •Hepatocellular carcinoma (a type of liver cancer) that cannot be removed by surgery.
  •Renal cell carcinoma (a type of kidney cancer) that is advanced.
  •Thyroid cancer in certain patients with progressive, recurrent, or metastatic disease that does not respond to treatment with radioactive iodine.
  
  Sorafenib tosylate is also being studied in the treatment of other types of cancer.
  

• CAS Registry Number:

  475207-59-1

• Synonyms:

  ;SORAFENIB-D3;4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate;N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea Tolsylate;Sorafenib TsOH salt;

• Molecular Formula:

  C₂₁H₁₆ClF₃N₄O₃·C₇H₈SO

• Molecular Weight:

  637.03

• Molecular Structure:

  

• Company:

  Jinan Chenghishaungda Chemical Co.,LTD     [ China ]        

• Contact:

  Allen

• Tel:

  15689693073

• Fax:

  0531-58897032

• Email:

  3118607598@qq.com